--Program Agency Announcement (PAA) for the fiscal year 2004 (FY04) Department of Defense Prostate Cancer Research Program (PCRP) to support innovative research directed toward eliminating prostate cancer.

The Department of Defense Fiscal Year 2004 Prostate Cancer Research Program (PCRP) announced a supplement to its original November 2003 solicitation, introducing a new funding mechanism called the Clinical Trial Development Award (CTDA). This addition expands the program’s support options aimed at advancing innovative research focused on eliminating prostate cancer. The CTDA solicitation was released on January 20, 2004, with a proposal submission deadline set for April 13, 2004, by 5:00 PM Eastern Time. Applicants are required to submit one electronic PDF version of their proposals. Detailed information regarding the award, including eligibility, evaluation criteria, and submission guidelines, is provided on the CDMRP website. This funding opportunity is part of the Department of Defense’s efforts through the PCRP to encourage research innovations. In addition to the CTDA, ten other mechanisms were previously announced under the program for FY04. Applicants and interested parties can access all necessary documents and further program information on the CDMRP site, which also offers resources on other sponsored programs. For technical assistance or questions related to submission formats and documentation, contact options include phone, fax, and email via the provided CDMRP contacts.